Relmada Therapeutics, Inc.
RLMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,857 | $4,092 | $5,396 | $44,443 |
| Short-Term Investments | $41,052 | $92,232 | $142,927 | $167,466 |
| Receivables | $0 | $0 | $512 | $86 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $886 | $1,185 | $4,035 | $11,302 |
| Total Curr. Assets | $45,796 | $97,509 | $152,870 | $223,298 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $22 | $43 | $35 | $28 |
| Total NC Assets | $22 | $43 | $35 | $28 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $45,818 | $97,552 | $152,905 | $223,326 |
| Liabilities | – | – | – | – |
| Payables | $4,131 | $3,506 | $5,262 | $11,193 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6,161 | $8,689 | $7,207 | $3,868 |
| Total Curr. Liab. | $10,291 | $12,195 | $12,469 | $15,061 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $10,296 | $12,195 | $12,469 | $15,061 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $30 | $30 | $30 | $28 |
| Retained Earnings | -$640,882 | -$560,903 | -$462,111 | -$305,067 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $676,374 | $646,230 | $602,517 | $513,304 |
| Total Equity | $35,522 | $85,357 | $140,436 | $208,265 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $45,818 | $97,552 | $152,905 | $223,326 |
| Net Debt | -$3,857 | -$4,092 | -$5,396 | -$44,443 |